Literature DB >> 11705092

Drug-induced urticaria. Recognition and treatment.

D Shipley1, A D Ormerod.   

Abstract

Urticaria is the second most common cutaneous manifestation of drug allergy. Drug-induced urticaria is seen in 0.16% of medical inpatients and accounts for 9% of chronic urticaria or angioedema seen in dermatology outpatient departments. Occurring within 24 hours of drug ingestion, it is most commonly caused by penicillins, sulfonamides and nonsteroidal anti-inflammatory drugs. Drug-induced urticaria is seen in association with anaphylaxis, angioedema, and serum sickness. Diagnosis requires a detailed history, knowledge of the most likely agents sometimes supplemented with in vitro and skin testing. For mild reactions, avoidance of the causative drug and treatment with antihistamines will suffice. For anaphylactic shock, treatment with epinephrine (adrenaline), corticosteroids and antihistamines is required. Patients should be educated to inform medical staff about previous drug reactions, and to avoid these and cross-reacting drugs if possible. Medical staff need to routinely enquire about allergy and avoid unnecessary prescriptions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705092     DOI: 10.2165/00128071-200102030-00004

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  6 in total

1.  Systemic delivery of atropine sulfate by the MicroDose Dry-Powder Inhaler.

Authors:  T E Corcoran; R Venkataramanan; R M Hoffman; M P George; A Petrov; T Richards; S Zhang; J Choi; Y Y Gao; C D Oakum; R O Cook; M Donahoe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-06-12       Impact factor: 2.849

2.  Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation.

Authors:  Nadia Ben-Fredj; Ferdaous Chahed; Najah Ben-Fadhel; Khadija Mansour; Haifa Ben-Romdhane; Randa Said El Mabrouk; Zohra Chadli; Donia Ghedira; Hichem Belhadjali; Amel Chaabane; Karim Aouam
Journal:  Eur J Clin Pharmacol       Date:  2022-10-18       Impact factor: 3.064

3.  Angioneurotic oedema with tadalafil: A rare case report.

Authors:  Rajnish Raj; Balwant Sinch Sidhu
Journal:  Indian J Psychiatry       Date:  2006-10       Impact factor: 1.759

4.  Mast cell activation in the skin of Plasmodium falciparum malaria patients.

Authors:  Panop Wilainam; Rungrat Nintasen; Parnpen Viriyavejakul
Journal:  Malar J       Date:  2015-02-07       Impact factor: 2.979

5.  Chronic urticaria and drug hypersensitivity in children.

Authors:  Carlo Mastrorilli; Roberto Bernardini; Lucia Liotti; Fabrizio Franceschini; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau; Francesca Mori; Fabio Cardinale; Francesca Saretta; Giovanni Simeone; Marcello Bergamini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29

Review 6.  SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

Authors:  Natalijia Novak; Wenming Peng; Mirjam C Naegeli; Christina Galvan; Isabel Kolm-Djamei; Charlotte Brüggen; Beatriz Cabanillas; Peter Schmid-Grendelmeier; Alba Catala
Journal:  Allergy       Date:  2020-08-12       Impact factor: 14.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.